GlassScriptPhysician profile
Ryan Christopher Price
NPI 1255685046
$2,986.56
in general payments reported to CMS, 2019-2025
11 companies · $196 in 2025
The $196 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,043 · 2020: $49.96 · 2021: $1,352 · 2022: $50.44 · 2023: $295 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $491.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cgg Medical INC | $2,119.00 | 2019-2021 | |
| Medtronic, INC. | $294.38 | 2021-2023 | Unid_pass |
| Zimmer Biomet Holdings, INC. | $196.41 | 2025 | G7, Avenir, Arcos |
| Bioventus LLC | $120.44 | 2021 | |
| Orthopediatrics Corp. | $64.51 | 2019 | |
| Medtronic USA, INC. | $55.33 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $53.94 | 2022-2023 | Exparel |
| Depuy Synthes Sales INC. | $39.34 | 2019-2020 | |
| Biomarin Pharmaceutical INC. | $17.47 | 2021 | |
| Amgen INC. | $14.28 | 2019 | |
| Stimwave Technologies Incorporated | $11.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Price listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.